A Novel Hybrid Compound LLP2A-Ale Both Prevented and Rescued the Osteoporotic Phenotype in a Mouse Model of Glucocorticoid-Induced Osteoporosis

Calcified Tissue International - United States
doi 10.1007/s00223-016-0195-6
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

A Novel Hybrid Compound LLP2A-alendronate Accelerates Open Fracture Healing in a Rabbit Model

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2019English

Anti-Osteoporotic Effects of Melatonin and Misoprostol in Glucocorticoid-Induced Osteoporosis: An Experimental Study

Journal of Surgery and Medicine
2019English

Glucocorticoid-Induced Osteoporosis

RMD Open
RheumatologyAllergyImmunology
2015English

A Novel Animal Model of Pruritus Induced by Successive Application of Glucocorticoid to Mouse Skin

Journal of Toxicological Sciences
MedicineToxicology
2011English

Prevention of Glucocorticoid Induced Osteoporosis

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1997English

Glucocorticoid-Induced Osteoporosis in Rheumatic Diseases

Clinics
Medicine
2010English

Glucocorticoid-Induced Osteoporosis: 2013 Update

Reumatismo
Rheumatology
2014English

Prevention and Treatment of Glucocorticoid-Induced Osteoporosis

Racionalna terapija
2018English

Denosumab in the Treatment of Glucocorticoid-Induced Osteoporosis: A Systematic Review and Meta-Analysis

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy